MedPath

Effect of ED-71 on the incident fractures in osteoporotic patients

Phase 3
Conditions
Osteoporosis
Registration Number
JPRN-jRCT2080220020
Lead Sponsor
Chugai Pharmaceutical Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Osteoporotic patients with at least one fragility fracture and/or those with low bone mineral density

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath